Acura Pharmaceuticals, Inc.

OTCPK:ACUR Stock Report

Market Cap: US$152.7k

Acura Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ACUR?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,956,3962.95%
General Public8,033,93012.1%
Individual Insiders13,374,58220.2%
Private Companies42,984,37564.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 11 shareholders own 87.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
64.8%
Abuse Deterrent Pharmaceuticals, LLC
42,984,375US$98.9k0%no data
13.4%
John Schutte
8,912,655US$20.5k0%no data
2.95%
Essex Woodlands Management, Inc.
1,956,396US$4.5k0%no data
1.25%
Bruce Wesson
829,548US$1.9k0%no data
0.97%
Robert Jones
643,555US$1.5k0%no data
0.87%
William Skelly
575,989US$1.3k0%no data
0.82%
Peter Clemens
545,430US$1.3k0%no data
0.75%
George Ross
495,503US$1.1k0%no data
0.73%
Albert Brzeczko
486,001US$1.1k0%no data
0.67%
Immanuel Thangaraj
447,647US$1.0k0%no data
0.66%
Robert Seiser
438,254US$1.0k0%no data